The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Maze Therapeutics Inc. has divulged apolipoprotein L1 (APOL1) inhibitors reported to be useful for the treatment of chronic kidney disease, focal segmental glomerulosclerosis, diabetic retinopathy, ...

AI has demonstrated considerable potential in diabetic foot (DF) management. AI-powered thermal imaging and predictive ...

Yo-yo” dieting -- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people with ...

南京鼓楼医院东南大学医学院肾脏病研究所的研究人员 Xue-qi Li 等人在《Acta Pharmacologica Sinica》期刊上发表了题为 “Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic ...

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area. Read more!

The researchers tested PEITC in rats that had diabetic nephropathy. Their results showed evidence that PEITC may help repair ...

First author Boris Kovatchev said: “The landmark 10-year, 1,440-person Diabetes Control and Complications Trial (DCCT), ...

A businessman died after becoming unwell at home, an inquest opening heard. Kevin Watts, of Lancaster Drive, Stanton Harcourt, died on January 13 this year. An inquest was opened into the ...

The global diabetic nephropathy market was valued at $1.9 billion in 2021, and is projected to reach $3.3 billion by 2031, growing at a CAGR of 6%. PORTLAND, OR, UNITED STATES, January 30, 2025 ...

XORTX’s presentation will be recorded and available after the conference on the Company’s website. About XORTX Therapeutics Inc.